Bookmarks Share Print

Shift Work Disorder Clinical Trial

Novartis Pharmaceuticals is sponsoring a clinical research trial for night shift workers who suffer from shift work disorder (SWD).

To learn more about shift work disorder, click here.

This study is designed to discover if the study drug can effectively improve alertness and increase wakefulness in patients with shift work disorder. It is also aimed to increase understanding of the safety and metabolism of the study drug.

During the study, patients will be required to undergo a variety of assessments including a physical exam, blood sampling, sleep monitoring, and attention testing.

Shift Work Disorder information image

Patients who participate in this trial must meet the following requirements:

  • Must be between the ages of 18-65 years old
  • Must be a permanent or rotating night shift worker who works at least 5 night shifts per month
  • Must work at least two shifts on consecutive nights
  • Must be willing to travel to the sleep center the morning after working two or more consecutive night shifts  
  • Must have problems with excessive sleepiness during your night shifts (feeling very sleepy, finding it difficult to concentrate, might even have difficulties to stay awake during the night shift)
  • Must NOT smoke more than ten cigarettes a day
  • Must have a body mass index (BMI) between 18-35

To see if you may be eligible, click here for a pre-screener/questionnaire. 

Patients who are eligible and decide to enroll in this trial:

  • May receive compensation for time and travel costs
  • Will not be charged to participate
  • May withdraw from the trial at any time, for any reason.

Find out if there is a shift work disorder clinical study location nearby.

Additional study locations may be listed as they open in the future. We encourage you to share this information via the links at the top of the page.

To easily access additional information about Novartis’s shift work disorder clinical trial, access clinicaltrials.gov and use the trial’s NCT number, NCT03141086, to search the trial.

To learn more about shift work disorder, click here.